Bone marrow transplant at TMH starts in November
Jamshedpur, Sept. 19: Steel City will have facility of bone marrow transplant from November for which Tata Main Hospital (TMH) will sign MOU with Stem Cell Bank’s international agency in New Delhi on Thursday, said Dr. Rajan Choudhary, GM (Medical Services), TMH.
Addressing a press conference at the hospital premises on Thursday, Dr. Choudhary informed that Jamshedpur has come out with a Comprehensive Cancer Care facility keeping in mind the increasing number of cases of the disease every year. The facilities include Bone Marrow Transplant with a special Bone Marrow Transplant Centre that has been developed. The procedure is successful in various medical conditions.
To make project successful, TMH and Meherbai Tata Memorial Hospital (MTMH) is working together for which a new team has been formed and once the unit starts functioning the patients won’t have to move outstation for treatment and will be provided top class medical facilities in Jamshedpur itself, added Dr. Choudhary.
He further informed that Meherbai Tata Memorial Hospital (MTMH) will serve as a level I cancer treatment Centre and can be regarded as an apex centre for research and complex treatment facility for the disease.
Being the level 1 research & complex treatment Centre, MTMH has already started offering Comprehensive Cancer Care (CCC) facility in Jamshedpur. While facilities at TMH would be used for Surgical Oncology, MTMH would offer Radiation Oncology. Medical Oncology available at TMH and MTMH is under the expert guidance of HOD, Medical Oncology Dr. Anil Kumar Dhar, VSM.
MTMH Director Dr. Sujata Mitra said that patients today have to visit metro cities for bone marrow transplant and pay hefty amount of Rs 10 lakh which adds upto Rs 13 lakh taking into account accommodation and other expenses. It may be noted that till date Jharkhand doesn’t have a bone marrow transplant facility.
Dr. Rajan Choudhary went on to say that Tata Trusts chairman Ratan Tata during his visit to Jamshedpur decided to upgrade the cancer facility in the city after which the 72-bed Meherbai Tata Memorial Hospital will soon become state-of-the-art cancer-care centre of Jharkhand. Tata Trusts provided the needed the support after which the the upgradation work is going on at a fast pace and we hope to start the centre by January 2019 after patients from Jamshedpur and Jharkhand won’t have to visit Kolkata, Mumbai and other metro cities for cancer treatment.
Experts say that high cost is involved for cancer treatment in the private sector and only around 20 % population can afford the same. Besides, there is limited infrastructure and skill available in the government health care sector as far as treatment of cancer is concerned. Moreover, healthcare facilities are primarily concentrated in West and South Indian states. Total costs of cancer treatment comes anywhere between Rs 4 lakh to Rs 10 lakh which involves expenses incurred in OPD & diagnostics, chemotherapy, radiation therapy, Oncosurgery etc.
As far as cancer cases in Jharkhand is concerned, at present around 33,000-34,000 cases are added every year and the trend is increasing. For example, in the year 2015, 32,035 new cases were added while in 2017, a total of 34,183 new cancer patients were added. The data from the Indian Council of Medical Research (ICMR) and collated from the hospitals of Jamshedpur, Ranchi and Bokaro further suggests that in the year 2020, number of new cancer cases may go up to 37,679 and by 2022 it would be around 40,205. Hence the significance of good quality treatment of cancer assumes greater importance in the State.
Dr. Dhar who has recently joined, is an ex-head of the department of Medical Oncology at the Army Research and Referral (R & R) in New Delhi. He has also served in important institutions like Fortis Memorial Research Institute, Artemis Hospital, Gurgaon. He had a post-doctoral training in Medical Oncology from Tata Memorial Hospital, Mumbai.
Also present at the press conference were Dr. Anil Kumar Dhar, Dr. KP Dubey and others.